MedPath

Fitness and Longevity in Exercise

Not Applicable
Completed
Conditions
HIV-1-infection
Aging
Registration Number
NCT03399136
Lead Sponsor
University of Maryland, Baltimore
Brief Summary

The study objective was to determine the safety and efficacy of aerobic exercise in older HIV-infected men in a randomized trial comparing different levels of exercise intensity.

Detailed Description

The study was a randomized trial of moderate-intensity versus high-intensity aerobic exercise (AEX) training in older HIV-infected adults. Funding was provided by K23 AG024896 (PI, Oursler) and the UMB Claude D. Pepper Older Americans Independence Center P60 AG12583 (PI, Goldberg).

The central hypothesis was that high-intensity AEX training is well-tolerated and significantly increases aerobic capacity in older HIV-infected adults.

The study met its objectives:

1. Scientific AIMS met:

1. High-intensity AEX training significantly increases aerobic capacity

2. Both moderate-intensity and high-intensity AEX training improve ambulatory function and endurance.

3. Activity of skeletal muscle oxidative enzymes is reduced, and associated with aerobic capacity.

2. Feasibility Objectives met:

1. AEX training is safe and well-tolerated in older HIV-infected adults.

2. Skeletal muscle punch biopsy is safe and well-tolerated in older HIV-infected adults.

3. Preliminary data was collected on plasma biomarkers of inflammation.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
31
Inclusion Criteria
  • HIV+
  • stable combination antiretroviral therapy (cART)
Exclusion Criteria
  • AIDS defining conditions in the prior six months
  • Conditions that increase the risk of exercise training per the American College of Sports Medicine (ACSM)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change from baseline Cardiorespiratory Fitness at 16 weeks16-weeks

Cardiorespiratory Fitness measured by VO2peak

Secondary Outcome Measures
NameTimeMethod
Change from baseline body composition at 16 weeks16-weeks

body composition measured as total and regional lean tissue and fat mass (DXA)

Change from baseline Six-minute walk distance at 16 weeks16-weeks

Distance walked at normal pace in 6 minutes

Change from baseline exercise endurance at 16 weeks16-weeks

exercise endurance measured as time on treadmill during modified Bruce protocol

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.